Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis
- PMID: 26690369
- PMCID: PMC4687146
- DOI: 10.1186/s12985-015-0446-6
Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis
Abstract
Middle-East Respiratory Syndrome coronavirus (MERS-CoV) was identified to cause severe respiratory infection in humans since 2012. The continuing MERS epidemic with a case-fatality of more than 30% poses a major threat to public health worldwide. Currently, the pathogenesis of human MERS-CoV infection remains poorly understood. We reviewed experimental findings from human primary cells and ex vivo human lung tissues, as well as those from animal studies, so as to understand the pathogenesis and high case-fatality of MERS. Human respiratory epithelial cells are highly susceptible to MERS-CoV and can support productive viral replication. However, the induction of antiviral cytokines and proinflammatory cytokines/chemokines are substantially dampened in the infected epithelial cells, due to the antagonistic mechanisms evolved by the virus. MERS-CoV can readily infect and robustly replicate in human macrophages and dendritic cells, triggering the aberrant production of proinflammatory cytokines/chemokines. MERS-CoV can also effectively infect human primary T cells and induce massive apoptosis in these cells. Although data from clinical, in vitro and ex vivo studies suggested the potential for virus dissemination, extrapulmonary involvement in MERS patients has not been ascertained due to the lack of autopsy study. In MERS-CoV permissive animal models, although viral RNA can be detected from multiple organs of the affected animals, the brain of human DPP4-transgenic mouse was the only extrapulmonary organ from which the infectious virus can be recovered. More research findings on the pathogenesis of MERS and the tissue tropisms of MERS-CoV may help to improve the treatment and infection control of MERS.
Similar articles
-
Increased Pathogenicity and Virulence of Middle East Respiratory Syndrome Coronavirus Clade B In Vitro and In Vivo.J Virol. 2020 Jul 16;94(15):e00861-20. doi: 10.1128/JVI.00861-20. Print 2020 Jul 16. J Virol. 2020. PMID: 32434886 Free PMC article.
-
Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus.J Virol. 2019 Mar 5;93(6):e01818-18. doi: 10.1128/JVI.01818-18. Print 2019 Mar 15. J Virol. 2019. PMID: 30626685 Free PMC article.
-
Modulation of the immune response by Middle East respiratory syndrome coronavirus.J Cell Physiol. 2019 Mar;234(3):2143-2151. doi: 10.1002/jcp.27155. Epub 2018 Aug 26. J Cell Physiol. 2019. PMID: 30146782 Free PMC article. Review.
-
CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome.J Virol. 2016 Dec 16;91(1):e01825-16. doi: 10.1128/JVI.01825-16. Print 2017 Jan 1. J Virol. 2016. PMID: 27795435 Free PMC article.
-
Animal models of Middle East respiratory syndrome coronavirus infection.Antiviral Res. 2015 Oct;122:28-38. doi: 10.1016/j.antiviral.2015.07.005. Epub 2015 Jul 17. Antiviral Res. 2015. PMID: 26192750 Free PMC article. Review.
Cited by
-
Chemokine Levels among Patients with Middle East Respiratory Syndrome Coronavirus Infection.Vaccines (Basel). 2023 May 31;11(6):1048. doi: 10.3390/vaccines11061048. Vaccines (Basel). 2023. PMID: 37376437 Free PMC article.
-
SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In Vivo.Microorganisms. 2023 Apr 13;11(4):1015. doi: 10.3390/microorganisms11041015. Microorganisms. 2023. PMID: 37110438 Free PMC article. Review.
-
CuMV VLPs Containing the RBM from SARS-CoV-2 Spike Protein Drive Dendritic Cell Activation and Th1 Polarization.Pharmaceutics. 2023 Mar 2;15(3):825. doi: 10.3390/pharmaceutics15030825. Pharmaceutics. 2023. PMID: 36986686 Free PMC article.
-
Animal models for COVID-19: advances, gaps and perspectives.Signal Transduct Target Ther. 2022 Jul 7;7(1):220. doi: 10.1038/s41392-022-01087-8. Signal Transduct Target Ther. 2022. PMID: 35798699 Free PMC article. Review.
-
Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein.Sci Rep. 2022 May 16;12(1):8108. doi: 10.1038/s41598-022-12252-y. Sci Rep. 2022. PMID: 35577892 Free PMC article.
References
-
- Middle East Respiratory Syndrome coronavirus, Disease outbreak news [http://www.who.int/csr/don/23-september-2015-mers-kuwait/en/]
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous